Newcastle-Upon-Tyne, England and Berlin, Germany -- QMDx utilises SCIENION's proprietary ultra-low volume liquid handling technologies to transfer biological material onto QMDx's novel biosensor. Each nanowire in the array is printed with molecular probes; with hundreds of nanowires in each silicon biosensor chip, the multiplexing potential is massive. The companies' longstanding relationship was cemented with QMDx's [...]

Every year, 2.6 million children die of starvation. Phenomenex is dedicated to helping reduce this number. For two days in mid-May, managing director of Phenomenex Italy, Mr. Alberto Albieri, and the wonderful Italian team held their annual meal-packing event with Stop Hunger Now Italia, packing 36,000 meals that will be sent to children in great [...]

Horizon Technology is pleased to announce the introduction of EcoLine filter products. EcoLine filters expand the Horizon Technology sample preparation offering for filter needs in the environmental market. Three types of filters will be offered, Toxicity Characteristic Leaching Procedure (TCLP) filters, Total Suspended Solids (TSS) filters, and Volatile Solids filters. These are quality filters composed [...]

Dolomite Microfluidics, the world leader in innovative microfluidic products, has seen significant growth in the sale of its Micro Droplet Systems, particularly for cell encapsulation applications. The only commercially available complete solution for cell encapsulation, microparticle production and nanoparticle synthesis, these systems are modular, scalable and easy to use, offering reliable production of identically sized [...]

OMAHA, Neb. -— Transgenomic, Inc. (NASDAQ: TBIO), a developer of the most flexible, sensitive and robust platform for liquid biopsies on the market, today announced that Mya Thomae has been named to its Board of Directors and Harjit Kullar, PhD, has been appointed Vice President of Marketing for the Biomarker Discovery and Genetic Assays and [...]

ST. LOUIS -- Sigma-Aldrich Corporation (NASDAQ: SIAL) announced today that the Cerilliant® brand within its Applied Diagnostics and Testing business unit has introduced five new stable-labeled internal standards of the antifungal agents fluconazole, itraconazole, ketoconazole, posaconazole, and voriconazole at 1.0 mg/mL concentrations. Antifungal agents offer critically ill or immunocompromised patients multiple treatment options against invasive [...]

SymCel, the company behind the revolutionary cell-based assay tool providing real time cellular bioenergetics measurements, is pleased to announce that its ground-breaking calScreener™ technology has secured nine installations across five different countries for a mixture of university institutions and pharmaceutical companies. To date, the geographic spread includes, four signings in Sweden, two signings in Switzerland, [...]

The American Society of Clinical Oncology (ASCO) today announced its first-ever clinical trial that will offer patients with advanced cancer access to molecularly-targeted cancer drugs and collect “real-world” data on clinical outcomes to help learn the best uses of these drugs outside of indications approved by the Food and Drug Administration (FDA). Plans for the [...]

OAKLAND, Calif.--Omicia, the leading clinical genomics company, today announced that it has been selected by Genomics England to provide clinical interpretation services for the 100,000 Genomes Project. For the first phase of the project Illumina will provide sequencing services, while Omicia will provide interpretation and clinical reports. Genomics England leads the UK’s national initiative to [...]

SAN FRANCISCO -- Twist Bioscience, a company focused on synthetic DNA, today announced the completion of a $37 million Series C financing. Led by Illumina, Inc., participants in the round include new investors Fidelity Management and Research Company and Foresite Capital Management LLC, as well as all existing investors including Nick and Joby Pritzker (through [...]